康希诺重磅推出优佩欣疫苗 为儿童健康保驾护航的创新之选
Jun 20, 2025 17:58 HKT | |
|
雲頂新耀加速全球佈局 耐賦康(R)與EVER001雙引擎釋放創新藥價值潛力
Jun 20, 2025 14:49 HKT | |
|
云顶新耀加速全球布局 耐赋康(R)与EVER001双引擎释放创新药价值潜力
Jun 20, 2025 14:42 HKT | |
|
NEFECON(R) and EVER001 Drive Synergistic Progress as Everest Medicines Advances
Jun 12, 2025 16:38 HKT | |
|
耐賦康(R)與EVER001協同發力 雲頂新耀推動腎病治療進入精準管理新階段
Jun 12, 2025 16:31 HKT | |
|
耐赋康(R)与EVER001协同发力 云顶新耀推动肾病治疗进入精准管理新阶段
Jun 12, 2025 16:26 HKT | |
|
Everest Medicines Presents Positive Results from Phase 1b/2a Clinical Trial of EVER001 for Primary Membranous Nephropathy at ERA 2025
Jun 09, 2025 12:52 HKT | |
|
雲頂新耀EVER001亮相ERA 2025 探索原發性膜性腎病治療新路徑
Jun 09, 2025 12:47 HKT | |
|
云顶新耀EVER001亮相ERA 2025 探索原发性膜性肾病治疗新路径
Jun 09, 2025 12:35 HKT | |
|
First patient dosed in YK012 trial-the world's first TCE therapy for primary membranous nephropathy
May 29, 2025 15:49 HKT |  |
|
Asia Summit on Global Health and Hong Kong International Medical and Healthcare Fair Wrap Up Successfully
May 28, 2025 19:57 HKT |  |
|
「國際醫療健康周」今日揭開序幕
May 27, 2025 12:34 HKT | |
|
「国际医疗健康周」今日揭开序幕
May 27, 2025 12:04 HKT | |
|
International Healthcare Week kicks off today
May 26, 2025 18:27 HKT | |
|
Southeast Asian stem cell leader Medeze launches voluntary conditional cash partial offer for 10% stake in SGX-listed Cordlife Group Limited
May 14, 2025 15:00 HKT |  |
|
雲頂新耀宣佈耐賦康(R)獲得中國國家藥品監督管理局完全批准 全面拓展IgA腎病治療人群
May 07, 2025 18:08 HKT | |
|
云顶新耀宣布耐赋康(R)获得中国国家药品监督管理局完全批准 全面拓展IgA肾病治疗人群
May 07, 2025 18:06 HKT | |
|
全產業鏈貫通的抗血清頭部平台商：江西生物持續引領行業發展
May 07, 2025 15:37 HKT | |
|
全产业链贯通的抗血清头部平台商：江西生物持续引领行业发展
May 07, 2025 15:35 HKT | |
|
Northway Biotech Launches Full-Service Viral Clearance Studies, Delivering Results Faster Than Industry Standards
May 05, 2025 19:30 HKT |  |
|
|
Next >>
|